Journal
CURRENT HIV/AIDS REPORTS
Volume 17, Issue 3, Pages 237-248Publisher
SPRINGER
DOI: 10.1007/s11904-020-00495-1
Keywords
Pediatric HIV; Immune-based therapeutics; Viral remission; Functional cure
Categories
Funding
- NIAID NIH HHS [P01 AI131276, R01 AI133712, P30 AI094189] Funding Source: Medline
- NICHD NIH HHS [R01 HD080459] Funding Source: Medline
- NIDCR NIH HHS [R01 DE025444] Funding Source: Medline
Ask authors/readers for more resources
Purpose of Review In the absence of antiretroviral therapy (ART), more than 50% of perinatally HIV-infected children die by 2 years of age. Early ART from infancy is therefore a global recommendation and significantly improves immune health, child survival, and disease outcome. However, even early treatment does not prevent or eradicate the latent reservoir necessitating life-long ART. Adherence to life-long ART is challenging for children and longstanding ART during chronic HIV infection led to higher risks of non-AIDS co-morbidities and virologic failure in infected children. Thus, HIV-infected children are an important population for consideration for immune-based interventions to achieve ART-free remission and functional cure. This review summarizes how the uniqueness of the early life immune system can be harnessed for the development of ART-free remission and functional cure, which means complete virus control in absence of ART. In addition, recent advances in therapeutics in the HIV cure field and their potential for the treatment of pediatric HIV infections are discussed. Recent Findings Preclinical studies and clinical trials demonstrated that immune-based interventions target HIV replication, limit size of virus reservoir, maintain virus suppression, and delay time to virus rebound. However, these studies have been performed so far only in carefully selected HIV-infected adults, highlighting the need to evaluate the efficacy of immune-based therapeutics in HIV-infected children and to design interventions tailored to the early life maturing immune system. Immune-based therapeutics alone or in combination with ART should be actively explored as potential strategies to achieve viral remission and functional cure in HIV-infected pediatric populations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available